• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells.

作者信息

Mathiasen I S, Colston K W, Binderup L

机构信息

Department of Biology, LEO Pharmaceutical Products, Denmark.

出版信息

J Steroid Biochem Mol Biol. 1993 Sep;46(3):365-71. doi: 10.1016/0960-0760(93)90226-m.

DOI:10.1016/0960-0760(93)90226-m
PMID:9831485
Abstract

EB 1089 is a novel vitamin D analogue which in vitro strongly inhibits the proliferation of U937 histiocytic lymphoma cells and MCF-7 breast cancer cells, with a potency of 50 to 100 times that of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. Studies of c-myc and c-fos expression in MCF-7 cells and of differentiation markers in U937 cells show that growth inhibition by EB 1089 is accompanied by induction of differentiation. The ability of EB 1089 to affect calcium metabolism in vivo in rats is decreased, compared to 1,25(OH)2D3. This low calcemic effect combined with the strong biological effect on cancer cells in vitro, makes EB 1089 an interesting candidate for treatment of cancer.

摘要

相似文献

1
EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells.
J Steroid Biochem Mol Biol. 1993 Sep;46(3):365-71. doi: 10.1016/0960-0760(93)90226-m.
2
Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo.
Biochem Pharmacol. 1988 Mar 1;37(5):889-95. doi: 10.1016/0006-2952(88)90177-3.
3
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.维生素D3类似物对人前列腺癌细胞系的作用：与1,25 - 二羟维生素D3的比较
Endocrinology. 1995 Jan;136(1):20-6. doi: 10.1210/endo.136.1.7530193.
4
Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.新型维生素D3衍生物，26-高-δ22-脱氢-1α,25(S)-二羟基维生素D3和26-高-δ22-脱氢-1α,25(R)-二羟基维生素D3：在c-myc mRNA产生及诱导HL-60细胞表型分化中的优先活性
Arch Biochem Biophys. 1990 Feb 1;276(2):310-6. doi: 10.1016/0003-9861(90)90725-e.
5
Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.1,25 - 二羟维生素D3和维生素D3类似物EB1089对胰岛素及胰岛素样生长因子-I刺激的人乳腺癌细胞生长的抑制作用
Eur J Cancer. 1996 May;32A(5):842-8. doi: 10.1016/0959-8049(95)00647-8.
6
Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.维生素D3类似物与他莫昔芬联合治疗对乳腺癌细胞生长的抑制作用。
Cancer Res. 1994 Nov 1;54(21):5711-7.
7
Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression.维生素D化合物和细胞外钙对人结肠腺癌来源的Caco-2细胞的体外生长控制：与c-myc癌基因和维生素D受体表达的关系
Int J Cancer. 1995 Sep 15;62(6):711-6. doi: 10.1002/ijc.2910620611.
8
1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.1,25(OH)₂-维生素D₃介导的HL-60细胞及其相关亚克隆中c-myc和1,25(OH)₂D₃受体mRNA的变化。
Mol Cell Endocrinol. 1993 Sep;95(1-2):51-7. doi: 10.1016/0303-7207(93)90028-i.
9
Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.1,25-二羟基维生素D3与EB 1089对小鼠肾脏和肠道25-羟基维生素D3-24-羟化酶的比较作用
J Bone Miner Res. 1995 Dec;10(12):1951-9. doi: 10.1002/jbmr.5650101215.
10
Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.新型维生素D类似物1α-羟基维生素D5对乳腺肿瘤前病变发展的预防作用
J Natl Cancer Inst. 1997 Feb 5;89(3):212-8. doi: 10.1093/jnci/89.3.212.

引用本文的文献

1
Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms.维生素 D 在乳腺癌中的多方面作用：基于遗传和途径的系统评价机制。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3349-3361. doi: 10.31557/APJCP.2024.25.10.3349.
2
EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells.EB1089 增强曲妥珠单抗联合抗雌激素药物在 HER2 阳性乳腺癌细胞中的抗增殖作用。
Int J Mol Sci. 2024 Mar 9;25(6):3165. doi: 10.3390/ijms25063165.
3
Vitamin D and Breast Cancer: Mechanistic Update.
维生素D与乳腺癌：机制新进展
JBMR Plus. 2021 Dec 10;5(12):e10582. doi: 10.1002/jbm4.10582. eCollection 2021 Dec.
4
Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.维生素 D 通路激活选择性地使信号转导和转录激活因子（STAT）蛋白失活，并抑制自然杀伤白血病大颗粒淋巴细胞中炎症细胞因子的产生。
Cytokine. 2018 Nov;111:551-562. doi: 10.1016/j.cyto.2018.09.016. Epub 2018 Nov 17.
5
Vitamin D Receptor Signaling and Cancer.维生素 D 受体信号与癌症。
Endocrinol Metab Clin North Am. 2017 Dec;46(4):1009-1038. doi: 10.1016/j.ecl.2017.07.007. Epub 2017 Sep 29.
6
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.一项确定口服LR-103（1α,24(S)-二羟基维生素D2）在晚期癌症患者中的最大耐受剂量和安全性的I期研究。
J Oncol Pharm Pract. 2015 Dec;21(6):416-24. doi: 10.1177/1078155214541572. Epub 2014 Jul 1.
7
Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.评估新一代维生素 D 类似物 MART-10 在体外和体内人胰腺癌细胞中的潜在治疗作用。
Cell Cycle. 2013 Apr 15;12(8):1316-25. doi: 10.4161/cc.24445. Epub 2013 Apr 2.
8
1,25-Dihydroxyvitamin D(3) regulates PTHrP expression via transcriptional, post-transcriptional and post-translational pathways.1,25-二羟维生素 D(3) 通过转录、转录后和翻译后途径调节甲状旁腺激素相关肽的表达。
Mol Cell Endocrinol. 2011 Aug 6;342(1-2):32-40. doi: 10.1016/j.mce.2011.05.025. Epub 2011 Jun 1.
9
EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.EB1089抑制甲状旁腺激素相关蛋白增强的人前列腺癌细胞骨转移和异种移植瘤生长。
Mol Cancer Ther. 2009 Jul;8(7):1787-98. doi: 10.1158/1535-7163.MCT-09-0064. Epub 2009 Jul 7.
10
Bioavailability of seocalcitol IV: evaluation of lymphatic transport in conscious rats.静脉注射司骨化醇的生物利用度：清醒大鼠淋巴转运的评估。
Pharm Res. 2006 Nov;23(11):2681-8. doi: 10.1007/s11095-006-9109-z. Epub 2006 Oct 18.